The European Cancer Congress 2013

esmo38 estro32
login
My congress planner

The 2011 European Multidisciplinary Cancer Congress introduced in highlights

For those of you who didn't get the chance to participate at the 2011 European Multidisciplinary Cancer Congress, here is a series of short video introductions.

 

 

ECCO President Prof Michael Baumann discusses the European Multidisciplinary Cancer Congress 2011 in Stockholm

The importance of a multidisciplinary approach to the development of cancer treatments is outlined by Michael Baumann.  President of ECCO, Professor Baumann speaks about the concrete outcomes of the 2011 European Multidisciplinary Cancer Congress in Stockholm. Among the priorities are personalised medicine, taking the patient’s perspective, promoting oncopolicy and advancing the importance of a multidisciplinary  approach to cancer research, education, treatment and care, as well as clinical trials.

Prof Michael Baumann, President of the European CanCer Organisation, Brussels, Belgium

 

 

Opportunities for young oncologists attending the 2011 European Multidisciplinary Cancer Congress

Dr Katherina Farr explains how the European Multidisciplinary Cancer Congress offers young oncologists the opportunity to learn about the latest research results. It is important in this era of mutidisciplinary oncology that all aspects of cancer care are closely linked and have a good understanding of the major clinical advances in various treatment fields. The congress also provides networking opportunities valuable to a young oncologist’s career development.

Dr Katherina Farr, Aarhus University Hospital, Denmark

 

 

Benefits of the European Multidisciplinary Cancer Congress for young oncologists

Dr Duveken Fontein discusses the value of the Stockholm Congress to young oncologists. This meeting played an important role for inspiring young clinicians and offered a chance to meet and interact with leaders in the field from all disciplines. In addition, the ECCO-ESMO-ESTRO meeting provided an opportunity for younger researchers to present their work, both orally and in poster sessions. 

Dr Duveken Fontein, Leiden University Medical Center, The Netherlands





 
Key benefits of the European Multidisciplinary Cancer Congress

Dr Karin Tamas outlines some of the key benefits to clinicians attending the Stockholm Congress. The meeting offered the opportunity to learn about advances being achieved in many different fields thanks to the emphasis on multidisciplinary approaches to cancer therapy. Oncologists attending the meeting had the chance to interact with colleagues from a range of geographical and clinical backgrounds, to learn from them and to build valuable networking links.

Dr Karin Tamas - Szent Laszlo Teaching Hospital, Budapest, Hungary

  

PRINT THIS PAGE Page last modified: